HIV Antivirals Market Projected to Gain Significant Value through 2032
The global HIV antivirals market is expected to be worth US$ 30.6 billion in 2022. The HIV antivirals market is expected to reach US$ 47.0 Billion by the end of 2032, with sales revenue expected to register a 4.4% CAGR over the forecast period (2022 to 2032). According to a recent estimate, fixed-dose combos (FDCs) would command more than 83% of the HIV antivirals market in 2021. The demand for HIV antivirals is increasing due to growing prevalence of HIV across the globe. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), approximately 37.7 million people were infected with HIV in the world in 2020. Further, demand for HIV antivirals will also surge amid surging rate of unprotected sex and the use of contaminated needles or syringes. As per the National Youth Risk Behavior Survey provided by the Centers for Disease Control and Prevention (CDC), 38% of the respondents had sexual intercourse, and 9% had four or more sexual partners in the US, during hig...